Pre-Operative Substance Use Disorder is Associated with Higher Risk of Long-Term Mortality Following Bariatric Surgery.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
06 2023
Historique:
received: 13 01 2023
accepted: 28 03 2023
revised: 23 03 2023
medline: 5 6 2023
pubmed: 4 4 2023
entrez: 3 4 2023
Statut: ppublish

Résumé

Metabolic and bariatric surgery (MBS) has been associated with reduced all-cause mortality. While the number of subjects with substance use disorders (SUD) before MBS has been documented, the impact of pre-operative SUD on long-term mortality following MBS is unknown. This study assessed long-term mortality of patients with and without pre-operative SUD who underwent MBS. Two statewide databases were used for this study: Utah Bariatric Surgery Registry (UBSR) and the Utah Population Database. Subjects who underwent MBS between 1997 and 2018 were linked to death records (1997-2021) to identify any death and cause for death following MBS. All deaths (internal, external, and unknown reasons), internal deaths, and external deaths were the primary outcomes of the study. External causes of death included death from injury, poisoning, and suicide. Internal causes of death included deaths that were associated with natural causes such as heart disease, cancer, and infections. A total of 17,215 patients were included in the analysis. Cox regression was used to estimate hazard ratios (HR) of controlled covariates, including the pre-operative SUD. The subjects with pre-operative SUD had a 2.47 times higher risk of death as compared to those without SUD (HR = 2.47, p < 0.01). Those with pre-operative SUD had a higher internal cause of death than those without SUD by 129% (HR = 2.29, p < 0.01) and 216% higher external mortality risk than those without pre-operative SUD (HR = 3.16, p < 0.01). Pre-operative SUD was associated with higher hazards of all-cause, internal cause, and external cause mortality in patients who undergo bariatric surgery.

Identifiants

pubmed: 37012503
doi: 10.1007/s11695-023-06564-9
pii: 10.1007/s11695-023-06564-9
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1659-1667

Subventions

Organisme : NCRR NIH HHS
ID : R01 RR021746
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Adams TD, Davidson LE, Litwin SE, et al. Weight and Metabolic Outcomes 12 Years after Gastric Bypass. N Engl J Med. 2017;377(12):1143–55.
doi: 10.1056/NEJMoa1700459 pubmed: 28930514 pmcid: 5737957
Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17(4):796–802.
doi: 10.1038/oby.2008.610 pubmed: 19148123
Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.
doi: 10.1056/NEJMoa035622 pubmed: 15616203
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.
doi: 10.1056/NEJMoa066603 pubmed: 17715409
Davidson LE, Adams TD, Kim J, et al. Association of Patient Age at Gastric Bypass Surgery With Long-term All-Cause and Cause-Specific Mortality. JAMA Surg. 2016;151(7):631–7.
doi: 10.1001/jamasurg.2015.5501 pubmed: 26864395 pmcid: 5055061
Wiggins T, Guidozzi N, Welbourn R, et al. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: A systematic review and meta-analysis. PLoS Med. 2020;17(7):e1003206.
doi: 10.1371/journal.pmed.1003206 pubmed: 32722673 pmcid: 7386646
Lent MR, Benotti PN, Mirshahi T, et al. All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. Diabetes Care. 2017;40(10):1379–85.
doi: 10.2337/dc17-0519 pubmed: 28760742 pmcid: 5606311
Cardoso L, Rodrigues D, Gomes L, et al. Short- and long-term mortality after bariatric surgery: A systematic review and meta-analysis. Diabetes Obes Metab. 2017;19(9):1223–32.
doi: 10.1111/dom.12922 pubmed: 28244626
Sakran N, Sherf-Dagan S, Blumenfeld O, et al. Incidence and Risk Factors for Mortality Following Bariatric Surgery: a Nationwide Registry Study. Obes Surg. 2018;28(9):2661–9.
doi: 10.1007/s11695-018-3212-1 pubmed: 29627947
Benotti P, Wood GC, Winegar DA, et al. Risk factors associated with mortality after Roux-en-Y gastric bypass surgery. Ann Surg. 2014;259(1):123–30.
doi: 10.1097/SLA.0b013e31828a0ee4 pubmed: 23470583
Adams TD, Mehta TS, Davidson LE, et al. All-Cause and Cause-Specific Mortality Associated with Bariatric Surgery: A Review. Curr Atheroscler Rep. 2015;17(12):74.
doi: 10.1007/s11883-015-0551-4 pubmed: 26496931 pmcid: 5055056
Gribsholt SB, Thomsen RW, Svensson E, et al. Overall and cause-specific mortality after Roux-en-Y gastric bypass surgery: A nationwide cohort study. Surg Obes Relat Dis. 2017;13(4):581–7.
doi: 10.1016/j.soard.2016.10.007 pubmed: 27876334
Charlson FJ, Baxter AJ, Dua T, et al. Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010. Epidemiol Psychiatr Sci. 2015;24(2):121–40.
doi: 10.1017/S2045796014000687 pubmed: 25497332
Tedesco M, Hua WQ, Lohnberg JA, et al. A prior history of substance abuse in veterans undergoing bariatric surgery. J Obes. 2013;2013:740312.
doi: 10.1155/2013/740312 pubmed: 23840947 pmcid: 3694550
Svensson CJ, Lundberg CE, Sandstrom TZ, et al. Opioid consumption in patients undergoing Roux-en-Y bariatric surgery compared with population controls with and without obesity. Surg Obes Relat Dis. 2022;18(1):107–16.
doi: 10.1016/j.soard.2021.08.010 pubmed: 34493454
Cerón-Solano G, Zepeda RC, Romero Lozano JG, Roldán-Roldán G, Morin JP. Bariatric surgery and alcohol and substance abuse disorder: a systematic review. Cir Esp (Engl Ed). 2021; S0009–739X(21)00109-3.
Azam H, Shahrestani S, Phan K. Alcohol use disorders before and after bariatric surgery: a systematic review and meta-analysis. Ann Transl Med. 2018;6(8):148.
doi: 10.21037/atm.2018.03.16 pubmed: 29862237 pmcid: 5952017
King WC, Chen JY, Belle SH, et al. Use of prescribed opioids before and after bariatric surgery: prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis. 2017;13(8):1337–46.
doi: 10.1016/j.soard.2017.04.003 pmcid: 5568488
White GE, Courcoulas AP, King WC. Drug- and alcohol-related mortality risk after bariatric surgery: evidence from a 7-year prospective multicenter cohort study. Surg Obes Relat Dis. 2019;15(7):1160–9.
doi: 10.1016/j.soard.2019.04.007
Kanji S, Wong E, Akioyamen L, et al. Exploring pre-surgery and post-surgery substance use disorder and alcohol use disorder in bariatric surgery: a qualitative scoping review. Int J Obes (Lond). 2019;43(9):1659–74.
doi: 10.1038/s41366-019-0397-x pubmed: 31213657
Ivezaj V, Benoit SC, Davis J, et al. Changes in Alcohol Use after Metabolic and Bariatric Surgery: Predictors and Mechanisms. Curr Psychiatry Rep. 2019;21(9):85.
doi: 10.1007/s11920-019-1070-8 pubmed: 31410716 pmcid: 7057935
Li L, Wu LT. Substance use after bariatric surgery: A review. J Psychiatr Res. 2016;76:16–29.
doi: 10.1016/j.jpsychires.2016.01.009 pubmed: 26871733 pmcid: 4789154
Heinberg LJ, Pudalov L, Alameddin H, et al. Opioids and bariatric surgery: A review and suggested recommendations for assessment and risk reduction. Surg Obes Relat Dis. 2019;15(2):314–21.
doi: 10.1016/j.soard.2018.11.019 pubmed: 30661954
Conason A, Teixeira J, Hsu CH, et al. Substance use following bariatric weight loss surgery. JAMA Surg. 2013;148(2):145–50.
doi: 10.1001/2013.jamasurg.265 pubmed: 23560285
Saules KK, Wiedemann A, Ivezaj V, et al. Bariatric surgery history among substance abuse treatment patients: prevalence and associated features. Surg Obes Relat Dis. 2010;6(6):615–21.
doi: 10.1016/j.soard.2009.12.008 pubmed: 20207591
Kim J, Kelley J, Davidson L, Richards N, Adams T. Depression and anxiety incidence during pregnancy between bariatric surgery patients and matched control subjects. Obes Surg. 2022;32(6):1962–8.
doi: 10.1007/s11695-022-06037-5 pubmed: 35352268
Kim J, Davidson L, Hunt S, et al. Association of prenatal substance use disorders with pregnancy and birth outcomes following bariatric surgery. Int J Obes (Lond). 2022;46(1):107–12.
doi: 10.1038/s41366-021-00964-6 pubmed: 34508153
Centers for Medicare and Medicaid Services. Chronic Conditions Data Warehouse. [cited 2021 2 November]; Available from: https://www2.ccwdata.org/web/guest/condition-categories-other .
Centers for Medicare and Medicaid Services. Other Chronic Health, Mental Health, and Potentially Disabling Chronic Conditions Algorithms. [cited 2023 3 March]; Available from: https://www2.ccwdata.org/documents/10280/19139421/other-condition-algorithms.pdf .
Centers for Medicare and Medicaid Services. CMS Chronic Conditions Data Warehouse (CCW) CCW Condition Algorithms. [cited 2023 5 March]; Available from: https://www2.ccwdata.org/documents/10280/19139421/other-condition-algorithms-reference-list.pdf
VanderWeele TJ, Ding P. Sensitivity Analysis in Observational Research: Introducing the E-Value. Ann Intern Med. 2017;167(4):268–74.
doi: 10.7326/M16-2607 pubmed: 28693043
Carlsson LMS, Sjoholm K, Jacobson P, et al. Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study. N Engl J Med. 2020;383(16):1535–43.
doi: 10.1056/NEJMoa2002449 pubmed: 33053284 pmcid: 7580786
Peterhansel C, Petroff D, Klinitzke G, et al. Risk of completed suicide after bariatric surgery: a systematic review. Obes Rev. 2013;14(5):369–82.
doi: 10.1111/obr.12014 pubmed: 23297762
Tindle HA, Omalu B, Courcoulas A, et al. Risk of suicide after long-term follow-up from bariatric surgery. Am J Med. 2010;123(11):1036–42.
doi: 10.1016/j.amjmed.2010.06.016 pubmed: 20843498 pmcid: 4296730
Steffen KJ, Engel SG, Wonderlich JA, et al. Alcohol and Other Addictive Disorders Following Bariatric Surgery: Prevalence, Risk Factors and Possible Etiologies. Eur Eat Disord Rev. 2015;23(6):442–50.
doi: 10.1002/erv.2399 pubmed: 26449524
King WC, Chen JY, Mitchell JE, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012;307(23):2516–25.
doi: 10.1001/jama.2012.6147 pubmed: 22710289 pmcid: 3682834
Poorolajal J, Haghtalab T, Farhadi M, et al. Substance use disorder and risk of suicidal ideation, suicide attempt and suicide death: a meta-analysis. J Public Health (Oxf). 2016;38(3):e282–91.
doi: 10.1093/pubmed/fdv148 pubmed: 26503486
Poorolajal J, Haghtalab T, Farhadi M, Darvishi N. Substance use disorder and risk of suicidal ideation, suicide attempt and suicide death: a meta-analysis. J Public Health (Oxf). 2016;38(3):e282–91.
Adams TD, Meeks H, Fraser A, et al. Long-term all-cause and cause-specific mortality for four bariatric surgery procedures. Obesity. 2023;31(2):574–85.
doi: 10.1002/oby.23646 pubmed: 36695060
Svensson J, Bergstrom J, Kaberg M, et al. Patterns of mortality risk among patients with substance use disorder: an opportunity for proactive patient safety? BMC Psychiatry. 2022;22(1):770.
doi: 10.1186/s12888-022-04437-6 pubmed: 36476580 pmcid: 9730660
Bohnert KM, Ilgen MA, Louzon S, et al. Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration. Addiction. 2017;112(7):1193–201.
doi: 10.1111/add.13774 pubmed: 28301070
Substance Abuse and Mental Health Services Administration. Behavioral Health Barometer: Utah, Volume 6. Indicators as measured through the 2019 National Survey on Drug Use and Health and the National Survey of Substance Abuse Treatment Services. HHS Publication No. SMA–20–Baro–19–UT. Rockville, MD: Substance Abuse and Mental Health Services Administration. 2020. Available from https://www.samhsa.gov/data/sites/default/files/reports/rpt32861/Utah-BH-Barometer_Volume6.pdf . Accessed 3 Mar 2023.

Auteurs

Jaewhan Kim (J)

Department of Physical Therapy, University of Utah, 520 Wakara Way, Salt Lake City, UT, 84108, USA. Jaewhan.kim@utah.edu.

Joshua Kelley (J)

Department of Physical Therapy, University of Utah, 520 Wakara Way, Salt Lake City, UT, 84108, USA.

Sayeed Ikramuddin (S)

Department of Surgery, University of Minnesota, 420 Delaware Street SE, Mayo Mail Code 195, Minneapolis, MN, 55455, USA.

Jake Magel (J)

Department of Physical Therapy, University of Utah, 520 Wakara Way, Salt Lake City, UT, 84108, USA.

Nathan Richards (N)

Intermountain Health Care, 5300 South State Street, Murray, UT, 84107, USA.

Ted Adams (T)

Division of Epidemiology, University of Utah, 295 Chipeta Way, Salt Lake City, UT, 84108, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH